Choi CM - Search Results

1

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer.

Kim DH, Park H, Choi YJ, Im K, Lee CW, Kim DS, Pack CG, Kim HY, Choi CM, Lee JC, Ji W, Rho JK. Kim DH, et al. Among authors: choi cm, choi yj. Biomark Res. 2023 Sep 13;11(1):80. doi: 10.1186/s40364-023-00517-1. Biomark Res. 2023. PMID: 37705067 Free PMC article.

2

Combined treatment with silibinin and epidermal growth factor receptor tyrosine kinase inhibitors overcomes drug resistance caused by T790M mutation.

Rho JK, Choi YJ, Jeon BS, Choi SJ, Cheon GJ, Woo SK, Kim HR, Kim CH, Choi CM, Lee JC. Rho JK, et al. Among authors: choi sj, choi cm, choi yj. Mol Cancer Ther. 2010 Dec;9(12):3233-43. doi: 10.1158/1535-7163.MCT-10-0625. Mol Cancer Ther. 2010. PMID: 21159609

3

The effect of acquired cisplatin resistance on sensitivity to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer cells.

Rho JK, Choi YJ, Choi YR, Kim SY, Choi SJ, Choi CM, Na II, Lee JC. Rho JK, et al. Among authors: choi sj, choi cm, choi yr, choi yj. Oncol Res. 2011;19(10-11):471-8. doi: 10.3727/096504012x13285365944337. Oncol Res. 2011. PMID: 22715590

4

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.

Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T, Abdel-Rahman M, Wang X, Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, Kim WS, Lee DH, Lee JS, Miller VA, Arcila M, Ladanyi M, Moonsamy P, Sawyers C, Boggon TJ, Ma PC, Costa C, Taron M, Rosell R, Halmos B, Bivona TG. Zhang Z, et al. Among authors: choi cm, choi yj. Nat Genet. 2012 Jul 1;44(8):852-60. doi: 10.1038/ng.2330. Nat Genet. 2012. PMID: 22751098 Free PMC article.

5

False-positive FDG-PET and bronchial anthracofibrosis.

Kim MA, Lee JC, Choi C. Kim MA, et al. J Thorac Oncol. 2012 Sep;7(9):1474. doi: 10.1097/JTO.0b013e318260ded4. J Thorac Oncol. 2012. PMID: 22895146 Free article. No abstract available.

6

Wig1 prevents cellular senescence by regulating p21 mRNA decay through control of RISC recruitment.

Kim BC, Lee HC, Lee JJ, Choi CM, Kim DK, Lee JC, Ko YG, Lee JS. Kim BC, et al. Among authors: choi cm. EMBO J. 2012 Nov 14;31(22):4289-303. doi: 10.1038/emboj.2012.286. Epub 2012 Oct 19. EMBO J. 2012. PMID: 23085987 Free PMC article.

7

Bronchial anthracofibrosis and macroscopic tissue pigmentation on EBUS-TBNA predict a low probability of metastatic lymphadenopathy in Korean lung cancer patients.

Kim MA, Lee JC, Choi CM. Kim MA, et al. Among authors: choi cm. J Korean Med Sci. 2013 Mar;28(3):383-7. doi: 10.3346/jkms.2013.28.3.383. Epub 2013 Mar 4. J Korean Med Sci. 2013. PMID: 23486741 Free PMC article.

8

Sensitive detection of EML4-ALK fusion oncoprotein of lung cancer by in situ proximity ligation assay.

Rho JK, Lee H, Park CS, Choi CM, Lee JC. Rho JK, et al. Among authors: choi cm. Clin Chem Lab Med. 2013 Sep;51(9):1843-8. doi: 10.1515/cclm-2013-0044. Clin Chem Lab Med. 2013. PMID: 23612660

9

The effect of Radachlorin® PDT in advanced NSCLC: a pilot study.

Ji W, Yoo JW, Bae EK, Lee JH, Choi CM. Ji W, et al. Among authors: choi cm. Photodiagnosis Photodyn Ther. 2013 May;10(2):120-6. doi: 10.1016/j.pdpdt.2013.01.004. Epub 2013 Mar 16. Photodiagnosis Photodyn Ther. 2013. PMID: 23769277 Clinical Trial.

10

Epithelial-mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4-ALK translocation.

Kim HR, Kim WS, Choi YJ, Choi CM, Rho JK, Lee JC. Kim HR, et al. Among authors: choi cm, choi yj. Mol Oncol. 2013 Dec;7(6):1093-102. doi: 10.1016/j.molonc.2013.08.001. Epub 2013 Aug 20. Mol Oncol. 2013. PMID: 23993685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page